Medwell Capital Announces that Mimetogen Pharmaceutical Inc. Completes Patient Recruitment in…
Medwell Capital Announces $2 Million Investment in Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals Enrolls 100th Patient in Phase II Clinical Trial for Dry Eye
Mimetogen Pharmaceuticals Completes Key Equity Financing
Montréal, Québec — October 7th, 2009 — Mimetogen Pharmaceuticals Inc. (“Mimetogen”), a privately held drug development company announced today that…
Mimetogen Pharmaceuticals Inc. Closes Series A Financing and Completes Exclusive Licensing Agreement with McGill…
Mimetogen Pharmaceuticals Inc. Secures Seed Financing from MSBi Capital
Montréal, Québec — November 28th, 2005